Disclaimer

Important Notice: The information contained on this website is provided for informational and educational purposes only and is intended to provide general information regarding VivoSim Inc. (NASDAQ: VIVS), including its business, technology, human 3D tissue models, pharmaceutical contract research services, market opportunities, regulatory environment, financial developments, and potential growth opportunities.

The information presented on this website should not be construed as investment, legal, accounting, tax, financial, medical, scientific, or other professional advice. Investing in securities involves substantial risk, including the possible loss of principal. Visitors should not make investment decisions based solely on information contained on this website.

Forward-Looking Statements

This website may contain forward-looking statements within the meaning of applicable securities laws.

Forward-looking statements may include statements concerning VivoSim’s future business plans, objectives, expectations, financial performance, revenue opportunities, commercialization strategy, market opportunities, technology development, customer adoption, regulatory developments, pharmaceutical applications, and other future events or conditions.

Forward-looking statements may be identified by words or phrases such as “may,” “could,” “will,” “expect,” “anticipate,” “intend,” “believe,” “plan,” “estimate,” “potential,” “target,” and similar expressions.

These statements are based on current assumptions, expectations, estimates, and information available at the time they are made. They are subject to risks, uncertainties, and other factors that could cause actual results, performance, or developments to differ materially from those expressed or implied by such statements.

References on this website to potential revenue opportunities, market size, future growth, commercialization, customer adoption, regulatory developments, or expected benefits of VivoSim’s technology should not be interpreted as guarantees of future results.

VivoSim Inc. undertakes no obligation to update or revise forward-looking statements except as required by applicable law.

No Investment Advice

Nothing contained on this website constitutes an offer to sell or a solicitation of an offer to buy any securities of VivoSim Inc. (NASDAQ: VIVS) or any other security.

The content provided on this website is not intended to constitute investment advice or a recommendation to purchase, sell, or hold VivoSim securities.

Information regarding VivoSim’s technology, including its NAMkind™ human 3D tissue models, liver and intestinal toxicity testing, pharmaceutical contract research opportunities, market potential, and regulatory environment is presented for informational purposes only.

Investors should not rely upon this website as the sole basis for making an investment decision. Investors are encouraged to conduct their own independent research and review VivoSim’s publicly available disclosures and regulatory filings and to consult qualified financial, legal, tax, or investment professionals before making any investment decision.

Accuracy of Information

While reasonable efforts are made to present useful and accurate information, TickerSpotlight does not warrant or guarantee that all information presented on this website is complete, accurate, reliable, current, or error-free.

Information may be derived from publicly available company materials, regulatory filings, investor presentations, press releases, third-party sources, and other publicly available information.

Information may change without notice.

Certain performance figures, market estimates, revenue targets, scientific results, and other information discussed on this website may represent company-reported information, estimates, projections, or forward-looking statements and should be evaluated accordingly.

Third-Party Content and Links

This website may contain links to third-party websites or references to third-party information, including links to regulatory filings, company resources, research materials, financial information, news sources, and other external websites.

TickerSpotlight does not control or endorse third-party websites, content, products, services, or information and does not assume responsibility for their accuracy, availability, completeness, or reliability.

Visitors should review the terms, policies, disclosures, and other applicable information provided by third-party websites before relying upon such information.

Limitation of Liability

To the fullest extent permitted by applicable law, TickerSpotlight, its owners, officers, directors, employees, affiliates, contractors, agents, and contributors shall not be liable for any direct, indirect, incidental, consequential, special, or other damages arising from or related to the use of, or reliance upon, information contained on this website.

Visitors use the information provided on this website at their own discretion and risk.

Stock Information

Any stock price information, market data, charts, trading information, financial statistics, valuation information, or other market-related information concerning VivoSim Inc. (NASDAQ: VIVS) is provided for informational purposes only.

Market data may be delayed, incomplete, inaccurate, or subject to change and should not be relied upon for trading or investment purposes.

Past stock performance is not indicative of future results.

SEC Filings

Investors should review VivoSim Inc.’s publicly available filings with the U.S. Securities and Exchange Commission (SEC), including applicable Forms 10-K, 10-Q, 8-K, registration statements, and other reports and disclosures.

Investors should rely on the Company’s official filings and disclosures when evaluating VivoSim’s financial condition, business operations, risks, and prospects.

Scientific and Company Information

Information concerning VivoSim’s scientific models, including NAMkind™, liver toxicity testing, intestinal toxicity testing, antibody-drug conjugate applications, reported model performance, and other scientific developments is presented for general informational purposes.

Reported scientific results should not be interpreted as a guarantee of future performance or as evidence that VivoSim’s models will produce the same results across all compounds, customers, studies, or development programs.

Similarly, references to potential cost savings, reduced drug-development risk, improved candidate selection, or reduced reliance on animal testing represent potential benefits and should not be interpreted as guaranteed outcomes.

Copyright

© 2026 Sphere 3D Corp. All Rights Reserved.